USPTO 2015–2025 USPTO PatentsView US Corporation

Caisson Interventional LLC

USPTO PatentsView assignee record - 30 granted patents across 4 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Caisson ranks #10,273 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 4 technology areas.

#10,273
of 49,997 US assignees by volume
45th percentile
by Innovation Score (33.7/100)
19.0
avg claims per patent
-12%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10273 · US Corporation #10,273 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-SMALL 30 grants
  • UPPER-Q #10,273/49,997
  • PHOTO-FINISH CamPlex
  • CPC-NARROW A61F · 4 areas
  • INNOV-THIN 33.7/100
  • CLAIMS-RICH 19.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -12% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: CamPlex, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Caisson’s 33.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Caisson

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Caisson's Innovation Score is 33.7/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Caisson?

Each dot is one of Caisson’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Caisson’s own 19.0 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Caisson vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 29.93030.1 0510152025 Granted patents (volume) Avg claims / patent Coorstek KK - 30, 5.07Coorstek KKCrititech, Inc. - 30, 19.9CrititechCUB Elecparts Inc. - 30, 9CUB ElecpartsCurexo, Inc. - 30, 9.73CurexoCamPlex, Inc. - 30, 20.1CamplexCandela Corporation - 30, 15.63CandelaCarl Zeiss MultiSEM GmbH - 30, 22.1Carl Zeiss Multis…Cellphone-Mate, Inc. - 30, 22.37Cellphone-mateCaisson Interventional LLC - 30, 19Caisson Intervent…
Caisson vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Caisson's grants concentrate

Caisson Interventional LLC is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2023. By volume, Caisson sits between Coorstek KK and Cellphone-Mate, Inc..

Caisson's three-year grant acceleration

Caisson Interventional LLC shows 6 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Caisson's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Caisson holds 30 patents at rank #10,281, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Caisson

By rank, the assignees closest to #10,281 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Caisson's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Caisson, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Caisson ranks #216 of 3,082 assignees by patent count in that subclass.

Caisson's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2015201620172018201920202021202220232024 2
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Caisson Interventional LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 6.7%
2016 3 10.0%
2017 4 13.3%
2018 3 10.0%
2019 4 13.3%
2020 5 16.7%
2021 3 10.0%
2022 3 10.0%
2023 1 3.3%
2024 2 6.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Caisson Interventional LLC's patent record in context - here's where to go next.

  • Caisson Interventional LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #10,273 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Caisson Interventional LLC against Coorstek KK, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 33.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.